US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 72.730
  • +0.470+0.65%
Close May 2 16:00 ET
  • 72.730
  • 0.0000.00%
Post 20:01 ET
6.19BMarket Cap-36.37P/E (TTM)

Verona Pharma Key Stats

Verona Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 87.913M--
--2025/Q2-- / 68.166M--
Apr 29, 20252025/Q156.956M / 41.264M--
Feb 27, 20252024/Q429.038M / 26.490M--
Nov 4, 20242024/Q34.343M / 1.533M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 87.913M--
--2025/Q2-- / 68.166M--
Apr 29, 20252025/Q156.956M / 41.264M--
Feb 27, 20252024/Q429.038M / 26.490M--
Nov 4, 20242024/Q34.343M / 1.533M--

Unlock Free Earnings Estimates

Verona Pharma Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More